Catalio Capital Management, LP

Catalio Capital Management, LP reported 47 holdings worth US$538M as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Catalio Capital Management, LP reported 47 holdings worth US$538M as of Sep 30, 2026. Largest: Avalyn Pharma Inc., Bristol-Myers Squibb Company and BridgeBio Pharma, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
47
Value as reported
US$538M

The filing in full

CompanySharesValue as reported% of portfolio
Avalyn Pharma Inc.1.7MUS$48.4M9.0%
Bristol-Myers Squibb Company500KUS$31.2M5.8%
BridgeBio Pharma, Inc.425KUS$28M5.2%
Parabilis Medicines, Inc.824KUS$26.6M4.9%
Johnson & Johnson99,496US$26.3M4.9%
Arrowhead Pharmaceuticals, Inc.315KUS$20.6M3.8%
Syndax Pharmaceuticals, Inc.1.02MUS$19.2M3.6%
Definium Therapeutics, Inc.498KUS$19M3.5%
Celcuity Inc.231KUS$18.3M3.4%
Septerna, Inc.454KUS$17.8M3.3%
Guardant Health, Inc.92,579US$16.5M3.1%
Protagonist Therapeutics, Inc.112KUS$15.8M2.9%
10x Genomics, Inc.164KUS$14.8M2.8%
Amylyx Pharmaceuticals, Inc.506KUS$14.7M2.7%
Mineralys Therapeutics, Inc.583KUS$14.7M2.7%
Edwards Lifesciences Corporation161KUS$13.9M2.6%
Corvus Pharmaceuticals, Inc.1.02MUS$11.8M2.2%
Veradermics, Incorporated95,646US$11.6M2.2%
Disc Medicine, Inc.173KUS$11.3M2.1%
Odyssey Therapeutics, Inc.458KUS$10.2M1.9%
4D Molecular Therapeutics, Inc.685KUS$9.8M1.8%
Ultragenyx Pharmaceutical Inc.602KUS$9.04M1.7%
BioMarin Pharmaceutical Inc.145KUS$8.7M1.6%
Annexon, Inc.1.99MUS$8.4M1.6%
Rhythm Pharmaceuticals, Inc.85,614US$8.15M1.5%
Structure Therapeutics, Inc.260KUS$8.13M1.5%
Nektar Therapeutics127KUS$7.68M1.4%
Immunocore Holdings plc212KUS$6.42M1.2%
Cogent Biosciences, Inc.168KUS$5.37M1.00%
Kailera Therapeutics, Inc.469KUS$5.35M0.99%
Natera, Inc.12,530US$5.18M0.96%
Fractyl Health, Inc.8.84MUS$4.81M0.89%
Kardigan, Inc.313KUS$4.61M0.86%
Eledon Pharmaceuticals, Inc.1.64MUS$4.14M0.77%
Heartflow, Inc.74,969US$3.73M0.69%
BridgeBio Oncology Therapeutics, Inc.700KUS$2.87M0.53%
Freenome, Inc.158KUS$2.49M0.46%
Protara Therapeutics, Inc.512KUS$1.56M0.29%
Karyopharm Therapeutics Inc.976KUS$1.19M0.22%
Hyperfine, Inc.1.3MUS$1.05M0.20%
Metagenomi Therapeutics, Inc.529KUS$561K0.10%
Sensei Biotherapeutics, Inc.14,718US$438K0.08%
Outset Medical, Inc.107KUS$322K0.06%
ADARx Pharmaceuticals, Inc.11,357US$226K0.04%
AtaiBeckley Inc.0US$00.00%
Axsome Therapeutics, Inc.0US$00.00%
Dianthus Therapeutics, Inc.0US$00.00%
Dyne Therapeutics, Inc.0US$00.00%
Gilead Sciences, Inc.0US$00.00%
Incyte Corporation0US$00.00%

Source

Download original · View original at SEC

Related